1. Home
  2. |Insights
  3. |SFIA - Business Decisions to Recall: New CPSC Expectations and How to Meet Them

SFIA - Business Decisions to Recall: New CPSC Expectations and How to Meet Them

Event | 10.23.14, 10:00 AM EDT - 11:00 AM EDT

The U.S. CPSC has sparked a storm of activity by its consideration of new rules for Voluntary Product Recalls. Within the last year, more and more companies have become increasingly aware & concerned with the imminent CPSC Voluntary Product Recall process, that will place significant burdens on manufacturers, and the uncertainties that these changes will mean to their bottom line.


These provisions, now under consideration, include the ability of the CPSC to examine internal company operations and dictate procedures to be followed by company employees. While cooperation in recalls may have been a sound tactic in the past, where will the lines be driven now? Companies are now faced with tough choices brought on by the increased penalties and less protection for trade secrets and confidential business information.


Cheryl Falvey is a panelist at this event.


For more information, please visit these areas: Litigation and Trial, Product Risk Management

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.